FindTrial
Sign In

Effect of Testosterone replacement on glycaemic control and insulin sensitivity in hypogonadal men with type 2 diabetes

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN57267165
Enrollment
20
Registered
2005-09-30
Start date
2003-02-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nutritional, Metabolic, Endocrine: Hypogonadism Nutritional, Metabolic, Endocrine Hypogonadism

Interventions

Testosterone replacement vs placebo

Sponsors

Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: Diabetic men above 30 yrs old with hypogonadism

Exclusion criteria

Exclusion criteria: Hormone manipulating therapy, inflammatory disease, infection, prostate carcinoma, elevated PSA

Design outcomes

Primary

MeasureTime frame
Efficacy of testosterone replacement—

Secondary

MeasureTime frame
Not provided at time of registration—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026